Belrise Industries Ltd BELRISE

Summary

Belrise is, today, almost entirely an auto-components story: a ₹7,528 crore Tier-1 auto-OEM manufacturer with FY26 PAT up 44% YoY to ₹478cr. Its aerospace exposure — a ~€350,000 equipment purchase and a UK acquisition of Chester Hall Precision Engineering Holdings (thrust reversers and nacelle components) — is real but, on every figure this research could locate, still a rounding error next to the core business.

This report's rating is therefore, transparently, a rating on the auto-components business Belrise actually is today, not on an aerospace thesis this research cannot yet size. Sell-side coverage is genuinely positive and improving: Jefferies has raised its target three times in a year, most recently to ₹280 (August 2026), and JM Financial has also maintained a bullish stance following the Chester Hall announcement. We anchor to that disclosed, credible coverage rather than attempt an aerospace-specific valuation this research cannot support with real numbers.

Net: BUY, on the auto-components fundamentals and the disclosed sell-side view — with the explicit caveat that the aerospace angle in this report's own remit is, for now, an option on a future that has not yet shown up in the numbers.

• A genuinely improving core business. Revenue and PAT have grown every year shown, with PAT growth (+44% FY26) outpacing revenue growth (+14%) — margin expansion, not just top-line momentum.
• Credible, improving sell-side coverage. Jefferies raised its target from ₹192 (initiation, September 2025) to ₹250 (June 2026) to ₹280 (August 2026) — a consistent upward revision pattern, not a single optimistic call.
• A statutory-auditor transition handled transparently — successor joint auditors named well ahead of the incumbent's AGM-end tenure.
• Real, if early, aerospace optionality. The Chester Hall acquisition gives Belrise a genuine, named foothold in nacelle/thrust-reverser manufacturing — small today, but a real asset, not a marketing claim.

• The aerospace story is not yet sizeable enough to underwrite on its own. This research could not find standalone aerospace revenue, margin, or order-book figures for Belrise — the Chester Hall deal size (reportedly ~£13.2m) is a rounding error against ~₹7,500cr of group revenue.
• Several specific claims about the Chester Hall deal could not be verified — its exact signing date, closing status, Chester Hall's own revenue, and any stated "~10% of revenue" medium-term aerospace target were all unconfirmed in this research.
• Basic valuation ratios disagree between sources. Price-to-book shown as 3.99x by one aggregator and 8.26x by another for the same date — not reconciled.
• Board composition and Chairman identity could not be confirmed beyond the CEO/MD's name.
• No credit rating could be located from any of the four major agencies.

• First disclosed standalone Chester Hall revenue/margin contribution.
• Confirmation of full board composition and Chairman identity.
• Further sell-side coverage and target revisions.

• Auto-sector cyclicality (dominant) — this remains, overwhelmingly, an auto-components stock.
• Aerospace-specific disclosure risk — too little is currently known to size that part of the story independently.
• Governance-visibility risk from the unconfirmed board/Chairman details.

Given aerospace is not yet separately disclosed, we do not attempt a segment valuation and instead anchor to disclosed sell-side coverage of the business as a whole, which has been consistently revised upward:

We adopt Jefferies' most recent, highest target as our base case given the consistent upward-revision pattern (three consecutive increases), rather than an average, since the trend itself is informative.

Aerospace-specific financials are not separately disclosed and are not reproduced here. Source: screener.in, tickertape.in, groww.in (11 Sep 2026); Jefferies/JM Financial coverage per secondary aggregation (Bing news snippets, MSN/EquityBulls, Financial Express, Business Today), not independently verified against original broker notes.